In-depth characterization of the immune response to Zika virus infection confirmed that cross-reactive antibodies to dengue and Zika could enhance infection, but also showed that antibodies to E protein domain III (EDIII) were specific to Zika virus and could protect mice from otherwise lethal Zika virus infection.